Increased EZH2 function in regulatory T cells promotes their capacity to suppress autoimmunity by driving effector differentiation prior to activation

Janneke G.C. Peeters,Stephanie Silveria,Merve Ozdemir,Srinivas Ramachandran,Michel DuPage
DOI: https://doi.org/10.1101/2024.04.05.588284
2024-04-10
Abstract:The immunosuppressive function of regulatory T (Treg) cells is essential for maintaining immune homeostasis. Enhancer of zeste homolog 2 (EZH2), a histone H3 lysine 27 (H3K27) methyltransferase, plays a key role in maintaining Treg cell function upon CD28 co-stimulation, and deletion in Treg cells causes autoimmunity. Here we assessed whether increased EZH2 activity in Treg cells would improve Treg cell function. Using an Ezh2 gain-of-function mutation, , we found that Treg cells expressing displayed an increased effector Treg phenotype and were poised for improved homing to organ tissues. Expression of in Treg cells led to more rapid remission from autoimmunity. H3K27me3 profiling and transcriptomic analysis revealed a redistribution of H3K27me3, which prompted a gene expression profile in naïve Treg cells that recapitulated aspects of CD28-activated Treg cells. Altogether, increased EZH2 activity promotes the differentiation of effector Treg cells that can better suppress autoimmunity.
Immunology
What problem does this paper attempt to address?